Allison Eddy
Last active: 2/3/2012

  1. Failure of antioxidant therapy to attenuate interstitial disease in rats with reversible nephrotic syndrome. Drukker A, Eddy AA (1998) J Am Soc Nephrol 9(2): 243-51
    › Primary publication · 9527400 (PubMed)
  2. Molecular insights into renal interstitial fibrosis. Eddy AA (1996) J Am Soc Nephrol 7(12): 2495-508
    › Primary publication · 8989727 (PubMed)
  3. Interstitial inflammation and fibrosis in rats with diet-induced hypercholesterolemia. Eddy AA (1996) Kidney Int 50(4): 1139-49
    › Primary publication · 8887271 (PubMed)
  4. Expression of genes that promote renal interstitial fibrosis in rats with proteinuria. Eddy AA (1996) Kidney Int Suppl : S49-54
    › Primary publication · 8731195 (PubMed)
  5. Expression and function of monocyte chemoattractant protein-1 in experimental nephrotic syndrome. Eddy AA, Warren JS (1996) Clin Immunol Immunopathol 78(2): 140-51
    › Primary publication · 8625556 (PubMed)
  6. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Eddy AA, Giachelli CM (1995) Kidney Int 47(6): 1546-57
    › Primary publication · 7643523 (PubMed)
  7. Neurologic manifestations of pediatric systemic lupus erythematosus. Steinlin MI, Blaser SI, Gilday DL, Eddy AA, Logan WJ, Laxer RM, Silverman ED (1995) Pediatr Neurol 13(3): 191-7
    › Primary publication · 8554655 (PubMed)
  8. Interstitial macrophages as mediators of renal fibrosis. Eddy AA (1995) Exp Nephrol 3(2): 76-9
    › Primary publication · 7773640 (PubMed)
  9. Xanthogranulomatous pyelonephritis in children. Etiology, pathogenesis, clinical and radiologic features, and management. Levy M, Baumal R, Eddy AA (1994) Clin Pediatr (Phila) 33(6): 360-6
    › Primary publication · 8200171 (PubMed)
  10. Protein restriction reduces transforming growth factor-beta and interstitial fibrosis in nephrotic syndrome. Eddy AA (1994) Am J Physiol 266(6 Pt 2): F884-93
    › Primary publication · 8023968 (PubMed)